Surgical Treatment of Breast Cancer in BRCA-Mutation Carriers.
作者信息
Özmen Vahit
机构信息
Department of General Surgery, İstanbul University İstanbul Medical Faculty, İstanbul, Turkey.
出版信息
J Breast Health. 2015 Jul 1;11(3):101-105. doi: 10.5152/tjbh.2015.0001. eCollection 2015 Jul.
Abstract
摘要
相似文献
1
Surgical Treatment of Breast Cancer in BRCA-Mutation Carriers.携带BRCA基因突变的乳腺癌患者的手术治疗
J Breast Health. 2015 Jul 1;11(3):101-105. doi: 10.5152/tjbh.2015.0001. eCollection 2015 Jul.
2
Breast cancer treatment in mutation carriers: surgical treatment.突变携带者的乳腺癌治疗：手术治疗
Minerva Ginecol. 2016 Oct;68(5):548-56. Epub 2016 Jan 28.
3
4
Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer.术前基因诊断对携带BRCA突变的乳腺癌患者的手术决策有影响。
World J Surg. 2018 May;42(5):1384-1390. doi: 10.1007/s00268-017-4342-7.
5
Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.基因突变诊断时机对携带BRCA1/BRCA2基因突变的乳腺癌患者手术决策及预后的影响
Ann Surg Oncol. 2016 Oct;23(10):3232-8. doi: 10.1245/s10434-016-5328-7. Epub 2016 Jun 23.
6
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.BRCA 突变携带者乳腺癌的手术治疗：系统评价与荟萃分析
Breast Cancer Res Treat. 2014 Apr;144(3):443-55. doi: 10.1007/s10549-014-2890-1. Epub 2014 Feb 25.
7
Preoperative genetic testing affects surgical decision making in breast cancer patients.术前基因检测影响乳腺癌患者的手术决策。
Gynecol Oncol. 2014 Aug;134(2):326-30. doi: 10.1016/j.ygyno.2014.05.028. Epub 2014 Jun 5.
8
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?BRCA 突变携带者诊断为卵巢癌后患乳腺癌的风险：预防性乳房切除术是否必要？
Gynecol Oncol. 2017 May;145(2):346-351. doi: 10.1016/j.ygyno.2017.02.032. Epub 2017 Mar 14.
9
Differences between screen-detected and interval breast cancers among BRCA mutation carriers.BRCA 基因突变携带者中筛查性乳腺癌与间期乳腺癌的差异。
Breast Cancer Res Treat. 2019 May;175(1):141-148. doi: 10.1007/s10549-018-05123-6. Epub 2019 Jan 23.
10
Association of Mutations and Anti-müllerian Hormone Level in Young Breast Cancer Patients.年轻乳腺癌患者的基因突变与抗苗勒管激素水平的关联
Front Endocrinol (Lausanne). 2019 Apr 11;10:235. doi: 10.3389/fendo.2019.00235. eCollection 2019.
引用本文的文献
1
Management of patients with BRCA mutation from the point of view of a breast surgeon.从乳腺外科医生的角度看BRCA突变患者的管理
Ann Med Surg (Lond). 2021 Apr 16;65:102311. doi: 10.1016/j.amsu.2021.102311. eCollection 2021 May.
本文引用的文献
1
Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers.预防性乳房切除术对 BRCA1/2 突变携带者的影响。
Breast Care (Basel). 2014 Dec;9(6):385-9. doi: 10.1159/000369592.
2
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.安吉丽娜·朱莉效应：名人的高知名度如何对癌症相关服务的提供产生重大影响。
Breast Cancer Res. 2014 Sep 19;16(5):442. doi: 10.1186/s13058-014-0442-6.
3
Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis.单侧乳腺癌后对侧预防性乳房切除术：一项系统评价和荟萃分析。
Ann Surg. 2014 Dec;260(6):1000-10. doi: 10.1097/SLA.0000000000000769.
4
Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.BRCA1/2 基因突变携带者且有单侧乳腺癌病史者行对侧预防性乳房切除术后总生存率的改善：一项前瞻性分析。
Int J Cancer. 2015 Feb 1;136(3):668-77. doi: 10.1002/ijc.29032. Epub 2014 Jul 8.
5
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.BRCA 突变携带者乳腺癌的手术治疗：系统评价与荟萃分析
Breast Cancer Res Treat. 2014 Apr;144(3):443-55. doi: 10.1007/s10549-014-2890-1. Epub 2014 Feb 25.
6
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.BRCA1 和 BRCA2 突变携带者的癌症风险：EMBRACE 前瞻性分析的结果。
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22. doi: 10.1093/jnci/djt095. Epub 2013 Apr 29.
7
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者同侧乳腺癌的风险。
Breast Cancer Res Treat. 2011 May;127(1):287-96. doi: 10.1007/s10549-010-1336-7. Epub 2011 Jan 9.
8
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2010 Nov 10(11):CD002748. doi: 10.1002/14651858.CD002748.pub3.
9
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.BRCA1 和 BRCA2 基因突变携带者可手术乳腺癌的局部治疗：保乳术与乳房切除术的比较。
Breast Cancer Res Treat. 2010 Jun;121(2):389-98. doi: 10.1007/s10549-010-0894-z. Epub 2010 Apr 22.
10
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.保乳治疗联合放疗是否适用于 BRCA1/2 突变携带者？长期结果及文献复习。
Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24.
Zotero 插件